Clinac BPO 7

Generic name:benzoyl peroxide
Dosage form: gel
Drug class:Topical acne agents

Medically reviewed by Drugs.com. Last updated on Feb 21, 2022.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Clinac BPO 7 Description

Clinac® BPO 7 (benzoyl peroxide) is a topical preparation containing 7% benzoyl peroxide as the active ingredient in a gel vehicle containing purified water, propylene glycol, Acrysorb® (brand of acrylates copolymer), PEG-400, carbomer 940, disodium EDTA, and sodium hydroxide.

The chemical structure for the active ingredient is:

benzoyl peroxide

C14H10O4 (anhydrous) 242.23

Clinac BPO 7 - Clinical Pharmacology

The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl Peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action combines with the mild keratolytic effect of benzoyl peroxide is believed to be responsible for its usefulness in acne.

Little is known about the percutaneous penetration, metabolism and excretion of benzoyl peroxide. Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by benzoyl peroxide in humans.

Indications and Usage for Clinac BPO 7

Clinac® BPO 7 is indicated for the topical treatment of mild to moderate acne vulgaris.

Contraindications

Clinac® BPO 7 should not be used in patients who have shown hypersensitivity to benzoyl peroxide or any of the other ingredients in this product.

Warnings

FOR EXTERNAL USE ONLY. KEEP OUT OF REACH OF CHILDREN. Avoid contact with eyes, eyelids, lips and mucous membranes. If inadvertent contact occurs, rinse area thoroughly with water. Contact with colored material, including fabric and hair, may r..